Treatment of chronic hepatitis C with recombinant alpha 2b interferon in kidney transplant recipients: preliminary results and side effects

Transplant Proc. 1995 Feb;27(1):948-50.

Authors

L Rostaing¹, J Izopet, E Baron, M Duffaut, J Puel, D Durand

Affiliation

¹ Unité de Transplantation d'Organes, CHU Rangueil, Toulouse, France.

PMID: 7879242

No abstract available

Publication types

Clinical Trial

MeSH terms

Adult
Aged
Aspartate Aminotransferases / blood
Chronic Disease
Creatinine / blood
Follow-Up Studies
Hemoglobins / analysis
Hepatitis C / therapy*
Humans
Immunosuppressive Agents / therapeutic use
Interferon alpha-2
Interferon-alpha / adverse effects
Interferon-alpha / therapeutic use*
Kidney Transplantation* / physiology
Leukocyte Count
Middle Aged
Platelet Count
Postoperative Complications / therapy
Postoperative Complications / virology
Recombinant Proteins
Time Factors
Viremia / therapy
gamma-Glutamyltransferase / blood

Substances

Hemoglobins
Immunosuppressive Agents
Interferon alpha-2
Interferon-alpha
Recombinant Proteins
Creatinine
gamma-Glutamyltransferase
Aspartate Aminotransferases